 Michael R. Minogue joined Abiomed in 2004, and serves as CEO, Chairman and President.For fiscal year 2017, Abiomed reported $445.3 million in revenue and reported diluted earnings per share was $1.17 for the year.As of March 2019, Michael R. Minogue was Chairman, CEO & President of the company, while Dr. David M. Weber was the Chief Operating Officer.